Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study, we identified 74 differentially expressed autophagy-related genes in
glioma
patients. Analysis using a Cox proportional hazard regression model showed that
MAPK8IP1
and SH3GLB1, two autophagy-related genes, were associated with the prognostic signature for
glioma
.
Glioma
patients from the CGGA batches 1 and 2, GSE4412 and TCGA datasets could be divided into high- and low-risk groups with different survival times based on levels of
MAPK8IP1
and SH3GLB1 expression. The autophagy-related signature was an independent predictor of survival outcomes in
glioma
patients.
MAPK8IP1
overexpression and SH3GLB1 knockdown inhibited
glioma
cell proliferation, migration and invasion, and improved Temozolomide sensitivity. These findings suggest autophagy-related genes like
MAPK8IP1
and SH3GLB1 could be potential therapeutic targets in
glioma
.
...
PMID:Autophagy-related gene expression is an independent prognostic indicator of glioma. 2897 40
Glioma
is one of the leading causes of death from cancer, and autophagy-related genes (ARGs) play an important role in
glioma
occurrence, progression, and treatment. In this study, the gene expression profiles and clinical data of
glioma
patients were obtained from The Cancer Genome Atlas (TCGA) and the Chinese
Glioma
Genome Atlas (CGGA), respectively. ARGs were obtained from the Human Autophagy Database. We analyzed the expression of the ARGs in
glioma
and found that 73 ARGs were differentially expressed in tumor and normal tissues. Univariate Cox regression analysis was used to identify prognostic differentially expressed ARGs (PDEARGs). Least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analyses were performed on the PDEARGs to determine the risk genes; and BRIC5, NFE2L2, GABARAP, IKBKE, BID, MAPK3, FKBP1B,
MAPK8IP1
, PRKCQ, CX3CL1, NPC1, HSP90AB1, DAPK2, SUPT20H, and PTEN were selected to establish a prognostic risk score model for TCGA and CGGA cohorts. This model accurately stratified patients with different survival outcomes, and the autophagy-related signature was also appraised as being an independent prognostic factor. We also constructed a prognostic nomogram using risk score, age, gender, WHO grade, isocitrate dehydrogenase (IDH) mutation status, and 1p/19q co-deletion status; and the calibration plots showed excellent prognostic performance. Finally, Pearson correlation analysis suggested that the ARG signature also played an essential role in the tumor immune microenvironment. In summary, we constructed and verified a novel autophagy-related signature that was tightly associated with the tumor immune microenvironment and could serve as an independent prognostic biomarker in gliomas.
...
PMID:An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas. 3319 68